Showing results (91-100 of 527) with videos related to
Sort By:
Pageof 53
International Journal of Alzheimer'S Disease|September 24, 2010
Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease DementiaMirko Bibl, Hermann Esselmann, Piotr Lewczuk, et al.The Lancet. Neurology|February 15, 2011
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort studyBrit Mollenhauer, Joseph J Locascio, Walter Schulz-Schaeffer, et al.Journal of Parkinson'S Disease|November 25, 2015
Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's DiseaseRagnhild E Skogseth, Kolbjorn Bronnick, Joana B Pereira, et al.JAMA Neurology|December 6, 2016
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal FluidMohammad Shahnawaz, Takahiko Tokuda, Masaaki Waragai, et al.Journal of Neurology|August 22, 2016
Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodiesFranc Llorens, Matthias Schmitz, Daniela Varges, et al.Biochimica Et Biophysica Acta|February 15, 2015
Improved preparation of nasal lavage fluid (NLF) as a noninvasive sample for proteomic biomarker discoveryBodo Schoenebeck, Caroline May, Christian Güldner, et al.Journal of Alzheimer'S Disease : JAD|February 8, 2011
CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's diseaseBrit Mollenhauer, Herrmann Esselmann, Claudia Trenkwalder, et al.Journal of Neurochemistry|July 3, 2019
Parkinson's disease biomarkers based on α-synucleinMuneera Fayyad, Safa Salim, Nour Majbour, et al.Brain : a Journal of Neurology|December 10, 2015
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodiesAnne Stuendl, Marcel Kunadt, Niels Kruse, et al.Stem Cell Research|October 18, 2020
Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 geneChih-Hsin Ou-Yang, Han-Yi Lin, Cheng-Yen Huang, et al.Pageof 53